JPH01135711A - Hair tonic - Google Patents
Hair tonicInfo
- Publication number
- JPH01135711A JPH01135711A JP29400587A JP29400587A JPH01135711A JP H01135711 A JPH01135711 A JP H01135711A JP 29400587 A JP29400587 A JP 29400587A JP 29400587 A JP29400587 A JP 29400587A JP H01135711 A JPH01135711 A JP H01135711A
- Authority
- JP
- Japan
- Prior art keywords
- hair
- substance
- oil
- hair tonic
- pulegone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004209 hair Anatomy 0.000 title claims abstract description 41
- 230000001256 tonic effect Effects 0.000 title abstract description 11
- 239000000126 substance Substances 0.000 claims abstract description 21
- HKZQJZIFODOLFR-UHFFFAOYSA-N piperitenone Chemical compound CC(C)=C1CCC(C)=CC1=O HKZQJZIFODOLFR-UHFFFAOYSA-N 0.000 claims abstract description 12
- SEZLYIWMVRUIKT-UHFFFAOYSA-N isopiperitenone Natural products CC(=C)C1CCC(C)=CC1=O SEZLYIWMVRUIKT-UHFFFAOYSA-N 0.000 claims abstract description 10
- QSIMLPCPCXVYDD-UHFFFAOYSA-N diosphenol Chemical compound CC(C)C1CCC(C)=C(O)C1=O QSIMLPCPCXVYDD-UHFFFAOYSA-N 0.000 claims abstract description 8
- NZGWDASTMWDZIW-MRVPVSSYSA-N (+)-pulegone Chemical compound C[C@@H]1CCC(=C(C)C)C(=O)C1 NZGWDASTMWDZIW-MRVPVSSYSA-N 0.000 claims abstract description 7
- NZGWDASTMWDZIW-UHFFFAOYSA-N Pulegone Natural products CC1CCC(=C(C)C)C(=O)C1 NZGWDASTMWDZIW-UHFFFAOYSA-N 0.000 claims abstract description 7
- USMNOWBWPHYOEA-UHFFFAOYSA-N alpha-thujone Natural products CC1C(=O)CC2(C(C)C)C1C2 USMNOWBWPHYOEA-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229930007459 p-menth-8-en-3-one Natural products 0.000 claims abstract description 7
- SEZLYIWMVRUIKT-VIFPVBQESA-N (+)-isopiperitenone Chemical compound CC(=C)[C@@H]1CCC(C)=CC1=O SEZLYIWMVRUIKT-VIFPVBQESA-N 0.000 claims abstract description 4
- POVACFJTDXZOQT-UHFFFAOYSA-N Psi-diosphenol Natural products CC(C)C1=C(O)C(=O)C(C)CC1 POVACFJTDXZOQT-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000004480 active ingredient Substances 0.000 claims abstract description 4
- 239000000341 volatile oil Substances 0.000 claims description 11
- 239000002075 main ingredient Substances 0.000 claims description 2
- 230000003779 hair growth Effects 0.000 abstract description 18
- 239000003921 oil Substances 0.000 abstract description 11
- 230000001737 promoting effect Effects 0.000 abstract description 8
- 150000002576 ketones Chemical group 0.000 abstract description 7
- -1 cyclocivenone Chemical compound 0.000 abstract description 4
- 150000001875 compounds Chemical class 0.000 abstract description 3
- 230000028327 secretion Effects 0.000 abstract description 3
- 235000017396 Menta cendrata Nutrition 0.000 abstract description 2
- 235000010672 Monarda didyma Nutrition 0.000 abstract description 2
- 241001062991 Pycnanthemum Species 0.000 abstract description 2
- 210000002374 sebum Anatomy 0.000 abstract description 2
- RLYSXAZAJUMULG-UHFFFAOYSA-N 6-methyl-3-propan-2-ylcyclohex-2-en-1-one Chemical compound CC(C)C1=CC(=O)C(C)CC1 RLYSXAZAJUMULG-UHFFFAOYSA-N 0.000 abstract 1
- 235000014743 Mentha arvensis var villosa Nutrition 0.000 abstract 1
- 244000220832 Mentha arvensis var. villosa Species 0.000 abstract 1
- WPGPCDVQHXOMQP-UHFFFAOYSA-N carvotanacetone Natural products CC(C)C1CC=C(C)C(=O)C1 WPGPCDVQHXOMQP-UHFFFAOYSA-N 0.000 abstract 1
- 239000000457 mentha pulegium l. herb oil Substances 0.000 abstract 1
- 231100000957 no side effect Toxicity 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 235000015961 tonic Nutrition 0.000 description 7
- 210000004761 scalp Anatomy 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 201000004384 Alopecia Diseases 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 102000001779 3-oxo-5-alpha-steroid 4-dehydrogenase Human genes 0.000 description 3
- 108010029908 3-oxo-5-alpha-steroid 4-dehydrogenase Proteins 0.000 description 3
- 208000001840 Dandruff Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000003676 hair loss Effects 0.000 description 3
- 230000003054 hormonal effect Effects 0.000 description 3
- 231100000508 hormonal effect Toxicity 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 206010068168 androgenetic alopecia Diseases 0.000 description 2
- 201000002996 androgenic alopecia Diseases 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 208000024963 hair loss Diseases 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 239000003410 keratolytic agent Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000003658 preventing hair loss Effects 0.000 description 2
- 239000000186 progesterone Substances 0.000 description 2
- 229960003387 progesterone Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 230000004215 skin function Effects 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 229960000716 tonics Drugs 0.000 description 2
- 229940124549 vasodilator Drugs 0.000 description 2
- 239000003071 vasodilator agent Substances 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- IZLVFLOBTPURLP-UHFFFAOYSA-N 2-Methoxy-4-nitrophenol Chemical compound COC1=CC([N+]([O-])=O)=CC=C1O IZLVFLOBTPURLP-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 244000302909 Piper aduncum Species 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- RZMKWKZIJJNSLQ-UHFFFAOYSA-M carpronium chloride Chemical compound [Cl-].COC(=O)CCC[N+](C)(C)C RZMKWKZIJJNSLQ-UHFFFAOYSA-M 0.000 description 1
- 229950003631 carpronium chloride Drugs 0.000 description 1
- 229940000425 combination drug Drugs 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 229940075894 denatured ethanol Drugs 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- 238000011597 hartley guinea pig Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- LXMSZDCAJNLERA-ZHYRCANASA-N spironolactone Chemical compound C([C@@H]1[C@]2(C)CC[C@@H]3[C@@]4(C)CCC(=O)C=C4C[C@H]([C@@H]13)SC(=O)C)C[C@@]21CCC(=O)O1 LXMSZDCAJNLERA-ZHYRCANASA-N 0.000 description 1
- 229960002256 spironolactone Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000003813 thin hair Effects 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は、特定のα、β−不飽和ケトン構造を有する物
質若しくはそれら物質を主たる成分として含有する精油
を有効成分として配合した新規な養毛料に関し、更に詳
しくは、頭髪及び頭皮の機能を先進又は正常化し、優れ
た養・育毛効果のある養毛料を提供することにある。Detailed Description of the Invention [Field of Industrial Application] The present invention provides a novel nutritional supplement containing as an active ingredient a substance having a specific α,β-unsaturated ketone structure or an essential oil containing such substance as the main ingredient. More specifically, the purpose of the present invention is to provide a hair nourishment that improves or normalizes the functions of the hair and scalp and has excellent nourishing and hair growth effects.
[従来の技術]
従来種々の養毛料が、禿頭、薄毛、フケ、脂漏などの生
理学的諸症状に対し、その予防や治療に用いられてきて
いる。[Prior Art] Various hair nourishing agents have been used for the prevention and treatment of various physiological symptoms such as baldness, thinning hair, dandruff, and seborrhea.
一般に、五毛料の配合薬剤、いわゆる養毛剤としては、
主に頭皮の血行促進、毛母細胞の活性化、頭皮の脂質分
泌抑制、頭髪への栄養補給などを目的として使用されて
おり、例えば、ビタミンE及びその誘導体、塩化カルプ
ロニウム、スウェルチアノーゲン(センブリエキス)、
レインーゲンなどの血管拡張剤、エストラジオール、エ
チニルエストラジオールなどの女性ホルモン剤、パント
テン酸及びその誘導体、セファランチン、モノニトログ
アヤコールなどの皮膚機能元進剤、サリチル酸、レゾル
シン、塩化ベンザルコニウムなどの角質溶解剤・殺菌剤
、グリチルレチン酸、アラントインなどの消炎剤、ビタ
ミン86などのビタミン類、メチオニン、セリンなどの
アミノ酸類など各種成分が用いられてきた。そして、そ
れらが配合された養毛剤を外用することによりフケ、痒
みを抑え、また脱毛を予防若しくは抑制したり、更には
発毛や育毛を促す効力を発揮させるべく期待されている
。In general, as a combination drug of Gomoryo, so-called hair growth agent,
It is mainly used for the purpose of promoting blood circulation in the scalp, activating hair matrix cells, suppressing scalp lipid secretion, and providing nutrition to the hair.For example, vitamin E and its derivatives, carpronium chloride, swertianogen extract),
Vasodilators such as Reingen, female hormones such as estradiol and ethinyl estradiol, skin function promoters such as pantothenic acid and its derivatives, cephalanthine and mononitroguaiacol, keratolytic agents such as salicylic acid, resorcin, and benzalkonium chloride. Various ingredients have been used, including disinfectants, anti-inflammatory agents such as glycyrrhetinic acid and allantoin, vitamins such as vitamin 86, and amino acids such as methionine and serine. By externally applying a hair tonic containing these ingredients, it is expected to suppress dandruff and itching, prevent or suppress hair loss, and furthermore exhibit the effect of promoting hair growth and growth.
また、近年男性ホルモンの過剰やアンバランスが脱毛の
原因になると言われ、抗アンドロケン剤の養毛剤への配
合が検討されており、特に男性型脱毛症には活性ホルモ
ンである5α−ジヒドロテストステロンの関与が示唆さ
れ、この生成を抑制すべく研究開発が行なわれている。In addition, in recent years, it has been said that excess or imbalance of male hormones is the cause of hair loss, and the addition of anti-androkening agents to hair growth preparations has been considered.In particular, for androgenetic alopecia, 5α-dihydrotestosterone, an active hormone, is being considered. It has been suggested that this may be involved, and research and development efforts are underway to suppress this generation.
すなわち、5α−ジヒドロテストステロンは、毛色内で
テストステロンがテストステロン−5α−リダクターゼ
により還元されて生成することが知られ、このことから
、テストステロン−5α−リダクターゼを阻害すること
で男性型脱毛症の発生を予防し、抑制できると考えられ
、。In other words, 5α-dihydrotestosterone is known to be produced when testosterone is reduced by testosterone-5α-reductase in hair color, and from this, inhibiting testosterone-5α-reductase can prevent the occurrence of androgenetic alopecia. It is thought that it can be prevented and suppressed.
テストステロン−5α−リダクターゼを特異的に阻害す
る拮抗剤が検索されている。そして、こうした抗アンド
ロゲン剤として、スピロノラクトン、プロゲステロンな
どの物質が見い出され、養毛剤としての有効性が報告さ
れている。Antagonists that specifically inhibit testosterone-5α-reductase are being sought. Substances such as spironolactone and progesterone have been discovered as such anti-androgen agents, and their effectiveness as hair restorers has been reported.
[発明が解決しようとする問題点]
養毛剤は、毛成長や発毛の促進、脱毛の予防、皮脂分泌
の抑制、またフケの発生、痒みに対して効力を有すると
共に、長期連用することから副作用や皮膚刺激性のない
、安全性の高いものが望まれている。[Problems to be solved by the invention] Hair tonics are effective in promoting hair growth, preventing hair loss, suppressing sebum secretion, and treating dandruff and itching. A highly safe product that does not cause skin irritation or skin irritation is desired.
しかし、従来の養毛剤は、−船釣に脱毛のr防、頭皮改
善的意味合いで有用であるものの、積極的に発毛・n毛
を促進するものが少なく、養・育毛効果を期待する上で
充分満足し得ないところがあった。However, although conventional hair nourishing agents are useful in terms of preventing hair loss and improving the scalp, there are few that actively promote hair growth and hair growth. There were some things that I wasn't completely satisfied with.
また、面記のプロゲステロンなとは、養毛剤としての効
果に於いて非常に有効であると報じられている反面、ホ
ルモン作用が認められ、それ以外のテストステロン−5
α−リダクターゼ阻害剤であるステロイド系化合物の場
合であっても、多少なりとも好ましくないホルモン作用
が現われる心配があり、この点ても充分満足し得るもの
でなかった。In addition, the progesterone mentioned in Men is reported to be very effective as a hair tonic, but on the other hand, it is also known to have hormonal effects, and other testosterone-5
Even in the case of steroidal compounds that are α-reductase inhibitors, there is a concern that they may exhibit some or all undesirable hormonal effects, and in this respect as well, they have not been fully satisfactory.
[問題を解決するための手段]
本発明者等は、前記事情に鑑み、更に優れた養・育毛効
果を有すると同時にホルモン作用などの悪影響がなく、
安全性の高い養毛剤を得るべく種々検討を重ねた結果、
特定のα、β−不飽和ケトン構造を有する物質若しくは
、それら物質を含有する精油は、優れた養・育毛促進作
用があり、養毛剤として極めて有効であって、しかも安
全性面でも良好であることを見い出し、この知見をもっ
て本発明を完成させるに到った。[Means for Solving the Problem] In view of the above circumstances, the present inventors have developed a method that has even more excellent nourishing and hair-growth effects, and at the same time has no adverse effects such as hormonal effects.
As a result of various studies to obtain a highly safe hair growth agent,
Substances with specific α,β-unsaturated ketone structures or essential oils containing these substances have excellent nourishing and hair growth promoting effects, are extremely effective as hair nourishing agents, and are also safe. With this knowledge, we have completed the present invention.
すなわち、本発明はプレゴン、ピペリテノン、イソピペ
リテノン、カルベノン、シクロシペノン、ディオスフェ
ノール、カラハナエノン、及びそれら物質を主たる成分
として含有する精油から選ばれる一種又は二種以上を配
合したことを特徴とする養毛剤に関する。That is, the present invention relates to a hair tonic containing one or more selected from pulegone, piperitenone, isopiperitenone, carbenone, cyclocypenone, diosphenol, carahanaenone, and essential oils containing these substances as main components.
以下、本発明の構成について説明する。The configuration of the present invention will be explained below.
本発明に於いて、必須に用いられるブレボン、ピペリテ
ノン、イソピペリテノン、カルベノン、シクロシペノン
、ディオスフェノール、カラハナエノンは、α、β−不
飽和ケトン構造を有する化合物であり、これら物質とし
ては、合成或いは天然植物から抽出、精製して得られる
精油からrrimしたものが使用できる。また、同様に
面記物質を主成分として含有する精油そのものであって
も好適に使用できる。例えば、プレゴンを65〜95%
含打しているベニ−ローヤルオイル、マウンテンミント
オイル、アメリカ野生ハツカオイルやピペリテノンを3
0%とプレゴンを65%含存するメグサバツカオイルな
どが特に好ましい精油として挙げることができる。In the present invention, brevon, piperitenone, isopiperitenone, carbenone, cyclocypenone, diosphenol, and carahanaenone are compounds having an α,β-unsaturated ketone structure, and these substances can be synthesized or derived from natural plants. It is possible to use rrim from the essential oil obtained by extraction and purification. Similarly, essential oil itself containing the listed substance as a main component can also be suitably used. For example, 65-95% pulegone
3 infused benny royal oil, mountain mint oil, American wild pepper oil and piperitenone.
Particularly preferred essential oils include Megsabatuka oil containing 0% and 65% pulegone.
そして、本発明に於いてはこれら特定の、α。In the present invention, these specific α.
β−不飽和ケトン構造を有する物質若しくは精油の中か
ら一種又は二種以上を選択し、必要に応じて組み合せて
配合して用いられる。One or more of the substances or essential oils having a β-unsaturated ketone structure are selected and used in combination as necessary.
配合+1は所期の目的を達成し得る面記物質の有効量を
用いることが肝要であり、限定的ではないが最終製品の
外観、臭いなどを考慮し、養毛剤基材中実質的に0.0
01〜5.0重量%、好ましくは0.1〜3.0重量%
の範囲で用いればよい。For Formulation +1, it is important to use an effective amount of the listed substance that can achieve the desired purpose, and considering the appearance, odor, etc. of the final product, although not limited, substantially 0. 0
01-5.0% by weight, preferably 0.1-3.0% by weight
It may be used within the range of .
かくて、本発明による前記特定の物質若しくは錆油は、
頭髪・頭皮に適用されることにより、その機能の光道又
は正常化を促し、優れた養・育毛効果が発揮される。ま
た、前記特定の物質及び蹟油はヒトでのパッチテスト、
家兎を用いた連続塗布試験による動物テストにより、皮
膚刺激かなく安全性が高いことも確認実証している。Thus, the specific substance or rust oil according to the present invention is
By applying it to the hair and scalp, it promotes the normalization or normalization of its functions and exhibits excellent nourishing and hair-growth effects. In addition, for the above specific substances and sesame oil, a patch test on humans,
An animal test using continuous application using domestic rabbits has confirmed that it is highly safe and does not cause skin irritation.
尚、本発明による養毛剤は、常法に従い、通常頭髪用製
品として知られている種々の形態の基材に配合して適用
することができる。これらを具体的に例示するとヘアト
ニック、ヘアリキッド、ヘアローション、ヘアクリーム
、ヘアリンス、ヘアシャンプー、ヘアセットローション
、ヘアスプレー、ヘアバック等が挙げられる。The hair tonic according to the present invention can be applied by blending it into various forms of base materials commonly known as hair products in accordance with conventional methods. Specific examples of these include hair tonics, hair liquids, hair lotions, hair creams, hair rinses, hair shampoos, hair setting lotions, hair sprays, hair bags, and the like.
そして、それら基材を構成する成分としては、精製水、
アルコール類、多価アルコール類、鉱物油・油脂類・高
級脂肪類・高級アルコール等の油剤、界面活性剤、美肌
用成分、紫外線吸収剤、増粘剤、色素、防腐剤、香料等
、通常化粧品に使用可能な成分から適宜選択して用いれ
ばよい。The components that make up these base materials include purified water,
Alcohols, polyhydric alcohols, mineral oils, fats and oils, higher fats, oils such as higher alcohols, surfactants, skin beautifying ingredients, ultraviolet absorbers, thickeners, pigments, preservatives, fragrances, etc., and regular cosmetics. The components may be appropriately selected and used from among the components that can be used.
また、本発明に於いては、萌記必須成分以外に通常養毛
剤成分として知られる血管拡張剤、女性ホルモン剤、皮
膚機能光進剤、局所刺激剤、角質溶解剤、消炎剤、殺菌
剤、ビタミン類、アミノ酸類、生薬抽出物類、保湿剤等
を必要に応じて養・育毛効果を一層高めることを期待し
、併用しても何ら差支えない。In addition to the essential ingredients of Moeki, the present invention also contains vasodilators, female hormones, skin function brighteners, local stimulants, keratolytic agents, anti-inflammatory agents, bactericidal agents, and vitamins, which are commonly known as hair tonic ingredients. , amino acids, herbal medicine extracts, moisturizing agents, etc., may be used in combination as necessary in the hope of further enhancing the nourishing and hair-growing effects.
[実施例コ
次に本発明について、実施例を挙げて更に説明する。こ
れらは、本発明を何ら限定するものではない。[Example] Next, the present invention will be further explained with reference to Examples. These do not limit the present invention in any way.
実施例[11
本発明の効果を確認すgため、以下に示すように、試料
を調製後、養・育毛促進効果試験を実施して評価、検討
を行な)た。Example [11] In order to confirm the effects of the present invention, samples were prepared as shown below, and then a test for promoting effect on nourishing and hair growth was carried out for evaluation and investigation).
試料の調製
エタノール60重量%水溶液を用い、表1に示すように
各検体を各濃度で添加して試料とした。尚、添加濃度は
重量%である。Preparation of Samples Using a 60% by weight aqueous ethanol solution, each specimen was added at various concentrations as shown in Table 1 to prepare samples. In addition, the addition concentration is weight %.
表 1
養・育毛促進効果試験
ハートレイ系モルモット(♂)、体重約400gを7匹
、1群とし、各モルモットの背部を除毛し、右側を対照
側として無塗布、左側を試験側として試料(1)〜(1
0)を各々 0.1mlずつ、1日2回、22日間塗布
した後、塗布部と無塗布部位の体毛をランダムに抜き、
対照側と試験側の体毛長、10本の平均の差を検定する
ことにより、伸長速度を求めモルモットの体毛の成長に
及ぼす影響を調べた。Table 1 Nutrient/Hair Growth Promotion Effect Test A group of 7 Hartley guinea pigs (female) weighing approximately 400 g were used. Hair was removed from the back of each guinea pig, and the right side was used as a control side without application, and the left side was used as a test side. 1)~(1
After applying 0.1 ml of each of 0) twice a day for 22 days, hair was randomly removed from the applied and non-applied areas.
By examining the difference in the average length of 10 hairs between the control side and the test side, the elongation speed was determined and the effect on the growth of the guinea pig's body hair was investigated.
その結果を表2に示す。The results are shown in Table 2.
(以下余白)
表 2
全動物数
表2に認められるように、試料(1)〜(9)、すなわ
ち本発明による物質または精油を塗布した場合には、い
ずれも対照側の無塗布部位、またエタノール溶液のみを
塗布したものに比べて、体毛成長が速く、特に試料(1
)〜(4)、(8)〜(9)ではそれが顕著であった。(Leaving space below) Table 2 Number of total animals As seen in Table 2, samples (1) to (9), that is, when the substance or essential oil according to the present invention was applied, the non-applied area on the control side, and Compared to those to which only ethanol solution was applied, hair growth was faster, especially in sample (1).
) to (4) and (8) to (9), this was remarkable.
このように本発明による物質や精油は、毛成長に対して
促進的であり、極めて優れた養毛剤であることがわかる
。As described above, it can be seen that the substances and essential oils according to the present invention promote hair growth and are extremely excellent hair nourishing agents.
実Mi例[2]ヘアローシヨン
(処方) (市1ii%)(1)
カンファー 0.05(2)
トウガラシチンキ 0.1(3) f
f1−メントール 0.1(4) ビ
タミンEアセテート 0.05(句 プレゴ
ン 1.5(6)変性エタノ
ール 60.0(71香料
適量(8)精製水
残量実施例[3]ヘアクリーム
(処方) (重量%)(1)
ステアリン酸 0.5(2)
スクワラン 1.0(3) 流
動パラフィン 40.0(4)ポリオ
キシエチレンセチル 1.5エーテル(20E、0
.)
(四 ポリオキシエチレンセチル 2.5エーテル
(’5 E、O,)
((へ) モノステアリン酸ソルビタン 1.5(
7) メチルパラベン 0.1(8)
トリエタノールアミン 1.0(9)
1.3−ブチレンゲリコール 5.0(10)
ピペリテノン 1.0(11)
香料 通量02)精製
水 残量実施例[4]ヘアシ
ヤンプー
(処方) (重量%)(11ア
ルキルエーテル硫酸ナトリウ 16.ロム
(2) ラウリン酸ジェタノールアミド 4.0(
3) プロピレングリコール 2.0(4
)防腐剤 適量(5)色素
適量(6) 香料
適量(7) ベニ−ローヤルオイ
ル 1.0(8)精製水
残量尚、実tJへ例 [2]〜[4]は、常法
に従って製造し、製品とした。Actual Mi example [2] Hair lotion (prescription) (city 1ii%) (1)
Camphor 0.05 (2)
Capsicum tincture 0.1 (3) f
f1-Menthol 0.1 (4) Vitamin E acetate 0.05 (Pulegone 1.5 (6) Denatured ethanol 60.0 (71 Fragrance
Appropriate amount (8) Purified water
Remaining amount example [3] Hair cream (formulation) (weight%) (1)
Stearic acid 0.5(2)
Squalane 1.0 (3) Liquid paraffin 40.0 (4) Polyoxyethylene cetyl 1.5 Ether (20E, 0
.. ) (4 Polyoxyethylene cetyl 2.5 ether ('5 E, O,) ((to) Sorbitan monostearate 1.5 (
7) Methylparaben 0.1 (8)
Triethanolamine 1.0 (9)
1.3-butylene gellicol 5.0 (10)
Piperitenone 1.0 (11)
Fragrance Amount 02) Purified water Remaining amount Example [4] Hair shampoo (prescription) (wt%) (11 Sodium alkyl ether sulfate 16. ROM (2) Lauric acid jetanolamide 4.0 (
3) Propylene glycol 2.0 (4
) Preservative appropriate amount (5) Pigment
Appropriate amount (6) Fragrance
Appropriate amount (7) Benny royal oil 1.0 (8) Purified water
Examples [2] to [4] were manufactured according to a conventional method and made into products.
[発明の効果]
以上説明した如く、本発明により、特定のα、β−不飽
和ケトン構造を有する物質若しくはそれら物質を主成分
とする精油が毛成長促進作用を有効に発揮することから
、これらを配合することで、頭髪、頭皮の機能を元進し
、正常化して、養・育毛の促進効果かはかられ、しかも
安全性の高い、Niめて優れた養毛料が得られたと共に
その提供が可能となったのである。[Effects of the Invention] As explained above, according to the present invention, substances having a specific α,β-unsaturated ketone structure or essential oils containing these substances as main components effectively exhibit a hair growth promoting effect. By incorporating Ni, the function of the hair and scalp is improved and normalized, and the effect of promoting nourishment and hair growth can be measured.In addition, we have obtained a hair nourishment that is highly safe and excellent in comparison to Ni. It is now possible to provide this.
以 」二 出願人 株式会社 小林コーセー2. Applicant: Kobayashi Kose Co., Ltd.
Claims (1)
ルベノン、シクロシペノン、ディオスフェノール、カラ
ハナエノン、及びそれら物質を主たる成分として含有す
る精油から選ばれる一種又は二種以上を有効成分として
配合したことを特徴とする養毛料。(1) A hair nourishment containing as an active ingredient one or more selected from pulegone, piperitenone, isopiperitenone, carbenone, cyclocypenone, diosphenol, carahanaenone, and essential oils containing these substances as main ingredients.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29400587A JPH01135711A (en) | 1987-11-24 | 1987-11-24 | Hair tonic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29400587A JPH01135711A (en) | 1987-11-24 | 1987-11-24 | Hair tonic |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH01135711A true JPH01135711A (en) | 1989-05-29 |
Family
ID=17802011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP29400587A Pending JPH01135711A (en) | 1987-11-24 | 1987-11-24 | Hair tonic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01135711A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996007403A1 (en) * | 1994-09-09 | 1996-03-14 | Shozo Koyama | Depressant of functions developed by molecule |
US6391324B2 (en) * | 2000-05-09 | 2002-05-21 | Unilever Home & Personal Care Usa, Division Of Conopco | Cosmetic skin care compositions containing pulegone |
US6588964B1 (en) | 2000-10-10 | 2003-07-08 | The Procter & Gamble Company | Fluid applicator |
US7001594B1 (en) | 2000-10-10 | 2006-02-21 | The Procter & Gamble Company | Scalp cosmetic compositions and corresponding methods of application to provide scalp moisturization and skin active benefits |
CN111228175A (en) * | 2020-02-26 | 2020-06-05 | 苏州工业园区黛宜菲化妆品有限公司 | A composition derived from plant for preventing alopecia and/or promoting hair growth |
-
1987
- 1987-11-24 JP JP29400587A patent/JPH01135711A/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996007403A1 (en) * | 1994-09-09 | 1996-03-14 | Shozo Koyama | Depressant of functions developed by molecule |
CN100430049C (en) * | 1994-09-09 | 2008-11-05 | 小山省三 | Depressant of functions developed by molecule |
US6391324B2 (en) * | 2000-05-09 | 2002-05-21 | Unilever Home & Personal Care Usa, Division Of Conopco | Cosmetic skin care compositions containing pulegone |
US6588964B1 (en) | 2000-10-10 | 2003-07-08 | The Procter & Gamble Company | Fluid applicator |
US7001594B1 (en) | 2000-10-10 | 2006-02-21 | The Procter & Gamble Company | Scalp cosmetic compositions and corresponding methods of application to provide scalp moisturization and skin active benefits |
CN111228175A (en) * | 2020-02-26 | 2020-06-05 | 苏州工业园区黛宜菲化妆品有限公司 | A composition derived from plant for preventing alopecia and/or promoting hair growth |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4603192B2 (en) | Hair scalp composition | |
JP2000226317A (en) | Hair lotion having improved properties in hair-protecting action, hair reduction-preventing action and action for lowering external action of androgenic alopecia and the resulting hair damage | |
TWI754607B (en) | Hair loss prevention formulation and use thereof | |
CN101835462A (en) | Hair care composition | |
JP6682600B2 (en) | Use to enhance hair quality using blackberry extract | |
JPH03188019A (en) | Testosterone-5alpha-reductase inhibitor | |
JPH026403A (en) | Cosmetic for hair and hair tonic | |
JPH07126146A (en) | Sin external preparation | |
US10111827B2 (en) | Hair loss prevention and restoration solution | |
KR19990018331A (en) | Hair growth promoting composition | |
JPS63115807A (en) | Cosmetic | |
JPS6253917A (en) | Hair cosmetic | |
KR20030036536A (en) | composite that have improvement effect vitality of scalp and hair | |
JPH01135711A (en) | Hair tonic | |
JPH0853327A (en) | Hair tonic composed of allantoin or its derivative | |
KR20120051199A (en) | Cosmetic compositions for hair or scalp to prevent hair loss and promote growing hair | |
JPH11269043A (en) | Cosmetic for scalp and hair | |
US5976515A (en) | Blood flow amount-improving agent comprising steroid derivative and cosmetic using same | |
KR101307304B1 (en) | Composition for treating hair or scalp to prevent hair loss and promote growing hair | |
JPS59172411A (en) | Hair tonic composition containing fatty acid | |
JP3382148B2 (en) | External preparation for head | |
JPH11302133A (en) | Cosmetic for scalp and hair | |
JPS63215611A (en) | Cosmetic | |
CA2145980C (en) | Hair revitalizing composition | |
JPH08113516A (en) | Composition for scalp |